Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery.

Shuang YangChengbin ZhouLei ZhangYueting XiongYongtao ZhengLiuguan BianXiaohui Liu

Published in: Proteomics. Clinical applications (2023)

We characterized an extensive proteomic landscape of BrMs and gliomas. These findings have promising implications for the development of targeted therapies for BrMs and gliomas.

Keyphrases

single cell
high grade
label free
high throughput
squamous cell carcinoma
small molecule
small cell lung cancer